AASS anticorps (C-Term)
Aperçu rapide pour AASS anticorps (C-Term) (ABIN950197)
Antigène
Voir toutes AASS AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 812-841, C-Term
-
Specificité
- This antibody reacts to AASS.
-
Réactivité croisée (Details)
- Species reactivity (tested):Human.
-
Purification
- Saturated Ammonium Sulfate (SAS) precipitation
-
Immunogène
- KLH conjugated synthetic peptide between 812-841 amino acids from the C-terminal region of human AASS.
-
Isotype
- Ig Fraction
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.25 mg/mL
-
Buffer
- PBS with 0.09 % (W/V) sodium azide as preservative
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid repeated freezing and thawing.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- AASS (Aminoadipate Semialdehyde Synthase (AASS))
-
Autre désignation
- AASS
-
Sujet
- This gene encodes a bifunctional enzyme that catalyzes the first two steps in the mammalian lysine degradation pathway. The N-terminal and the C-terminal portions of this enzyme contain lysine-ketoglutarate reductase and saccharopine dehydrogenase activity, respectively, resulting in the conversion of lysine to alpha-aminoadipic semialdehyde. Mutations in this gene are associated with familial hyperlysinemia.Synonyms: Alpha-aminoadipic semialdehyde synthase, LKR/SDH, mitochondrial
-
ID gène
- 10157
-
NCBI Accession
- NP_005754
-
Pathways
- SARS-CoV-2 Protein Interactome
Antigène
-